The X-linked intellectual disability protein IL1RAPL1 regulates excitatory synapse formation by binding PTPδ and RhoGAP2 by Valnegri, Pamela et al.
The X-linked intellectual disability protein IL1RAPL1
regulates excitatory synapse formation by binding
PTPd and RhoGAP2
Pamela Valnegri1,2, Chiara Montrasio1,2, Dario Brambilla3, Jaewon Ko4, Maria Passafaro1,2
and Carlo Sala1,5,∗
1CNR Institute of Neuroscience and Department of Pharmacology, University of Milan, 20129 Milan, Italy,
2Dulbecco
Telethon Institute, Rome, Italy,
3Department of Human Physiology, University of Milan, 20133 Milan, Italy,
4Department of Biochemistry, College of Life Science and Biotechnology, Yonsei University, 134 Shinchon-dong,
Seodaemun-gu, Seoul 120-749, South Korea and
5Neuromuscular Diseases and Neuroimmunology, Neurological
Institute Foundation ‘Carlo Besta’, 20133 Milan, Italy
Received July 13, 2011; Revised August 27, 2011; Accepted September 8, 2011
Mutations of the Interleukin-1-receptor accessory protein like 1 (IL1RAPL1) gene are associated with cogni-
tive impairment ranging from non-syndromic X-linked mental retardation to autism. IL1RAPL1 belongs to a
novel family of IL1/Toll receptors, which is localized at excitatory synapses and interacts with PSD-95. We
previously showed that IL1RAPL1 regulates the synaptic localization of PSD-95 by controlling c-Jun N-ter-
minal kinase activity and PSD-95 phosphorylation. Here, we show that the IgG-like extracellular domains
of IL1RAPL1 induce excitatory pre-synapse formation by interacting with protein tyrosine phosphatase
delta (PTPd). We also found that IL1RAPL1 TIR domains interact with RhoGAP2, which is localized at the
excitatory post-synaptic density. More interestingly, the IL1RAPL1/PTPd complex recruits RhoGAP2 at
excitatory synapses to induce dendritic spine formation. We also found that the IL1RAPL1 paralog,
IL1RAPL2, interacts with PTPd and induces excitatory synapse and dendritic spine formation. The interaction
o ft h eI L 1 R A P L 1f a m i l yo fp r o t e i n sw i t hP T P d and RhoGAP2 reveals a pathophysiological mechanism of
cognitive impairment associated with a novel type of trans-synaptic signaling that regulates excitatory
synapse and dendritic spine formation.
INTRODUCTION
IL1RAPL1 belongs to the IL1/Toll receptor family and shares
52% homology with the IL-1 receptor accessory protein
(IL-1RacP). Similar to other members of the IL-1 receptor
family, it is characterized by three extracellular Ig-like
domains, a transmembrane domain and an intracellular TIR
domain. However, unlike the family members, 150 additional
amino acids are located at the C-terminus. The homology with
IL-RacP is evenly distributed throughout the protein with the
exception of the last 150 amino acids, which are present
only in IL1RAPL1 and its paralog, IL1RAPL2. The ﬁrst
identiﬁed mutation in the IL1RAPL1 gene, which was
described by Carrie et al.( 1), is associated with a non-
syndromic form of mental retardation (MR). Similar to some
other genes involved in cognitive impairment (2–4),
IL1RAPL1 mutations are associated with a spectrum of cogni-
tive impairments ranging from MR to autism (5–11).
It has been previously demonstrated that the intracellular
C-terminal domain of IL1RAPL1 interacts with NCS-1 (12)
and that this interaction mediates the regulatory effect of
IL1RAPL1 over-expression on N-type voltage-gated calcium
channel activity in PC12 cells (13). More recently, we found
that the C-terminal tail of IL1RAPL1 interacts with PSD-95
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c-JunN-terminalkinase(JNK)phosphorylationatSer-295(14).
In this study, we found that both IL1RAPL1 and IL1RAPL2
can induce excitatory pre-synapse differentiation and dendritic
spine formation. Interestingly, although the extracellular
domain is sufﬁcient for inducing pre-synaptic differentiation,
both extracellular and intracellular TIR domains are required
for dendritic spine formation. Using afﬁnity chromatography,
we identiﬁed protein tyrosine phosphatase delta (PTPd)a sa
binding partner of IL1RAPL1 through its extracellular
domain. This interaction was conﬁrmed biochemically and
with an HEK cell trans-clustering assay using both
IL1RAPL1 and IL1RAPL2. Using yeast two-hybrid screening,
we found that the IL1RAPL1 intracellular TIR domain inter-
acts with RhoGAP2, which is localized at the excitatory
post-synaptic density. The interaction of IL1RAPL1 with
RhoGAP2 is required to induce dendritic spine formation.
Interestingly, we found that blocking the IL1RAPL1/PTPd
interaction abolished RhoGAP2 recruitment at excitatory
synapses, suggesting that IL1RAPL1 is involved in a novel
trans-synaptic signaling pathway that regulates excitatory
synapse and dendritic spine formation.
RESULTS
IL1RAPL1 induces the formation of functional excitatory
synapses
We have previously demonstrated that IL1RAPL1 over-
expression in neurons increases the excitatory synapse number
(measured as an increase in pre-synaptic contacts and dendritic
spine number) and that this ability does not depend on the
interaction between IL1RAPL1 and PSD-95 (14).
To better understand which domains of IL1RAPL1 are
involved in this function, we over-expressed full-length
IL1RAPL1 or two different mutants in neurons at days
in vitro 9 (DIV 9). The two mutants investigated were
HA-IL1RAPL1△C, which mimics the Y459X mutation that
was described in a boy affected by MR (1) and lacks part of
the TIR domain and the entire C-terminal tail (Fig. 1A), and
HA-IL1RAPL1△N, which has a deletion of the two external
N-terminal Ig-like domains on the extracellular surface
(Fig. 1A). Seven days after transfection, neurons were analyzed
for the dendritic spine number and shape, and the pre-synaptic
excitatory and inhibitory contacts were stained using
VGLUT1 and VGAT antibodies, respectively.
As shown in Figure 1B and quantiﬁed in the graph in
Figure 1C and D, both the extracellular and the intracellular
domains of IL1RAPL1 were necessary to increase the dendrit-
ic spine number (Fig. 1D, mean+SEM dendritic spine
number per 10 mm in neurons expressing GFP: 4.4+0.2;
HA-IL1RAPL1: 6.6+0.3; HA-IL1RAPL1△C: 3.6+0.3;
HA-IL1RAPL1△N: 4.1+0.4; ∗P , 0.05). However, the full-
length and mutant IL1RAPL1 constructs did not modify the
dendritic spine shape (Fig. 1C). Only the extracellular
domain of IL1RAPL1 was required to increase the excitatory
(VGLUT1-positive, Fig. 1E and G), but not the inhibitory
(VGAT-positive, Fig. 1F and H), pre-synaptic staining
(Fig. 1G, mean+SEM normalized ﬂuorescent intensity of
VGLUT1 staining in neurons expressing GFP: 92.9+6.3;
HA-IL1RAPL1: 388.1+33.9; HA-IL1RAPL1△C: 298.2+
21.9; HA-IL1RAPL1△N: 102.1+10.5; ∗P , 0.01).
We also studied the role of the IL1RAPL1 gene paralog,
IL1RAPL2, in neurons to understand whether this protein
shares properties with IL1RAPL1. Similar to IL1RAPL1,
IL1RAPL2 over-expression increased the dendritic spine
number without affecting morphology (Fig.1B–D, number
of spines per 10 mm in neurons expressing IL1RAPL2 com-
pared with GFP: 6.3+0.3 versus 4.4+0.2, ∗P , 0.05)
and promoted excitatory (Fig.1E and G, VGLUT1 staining
in neurons expressing HA-IL1RAPL2 compared with
neurons expressing GFP: 227.2+31.2 versus 92.9+6.3;
∗P , 0.01), but not inhibitory, pre-synaptic contact formation
in connecting neurons (Fig. 1F and H).
To visualize whether these extra synapses actively release
neurotransmitters, we performed an FM4–64 labeling experi-
ment. Neurons were transfected at DIV 9 with full-length
IL1RAPL1 or mutants (IL1RAPL1△C and IL1RAPL1△N)
andGFPtovisualizetransfectedneurons,usingimmunoﬂuores-
cence. Seven days after transfection, pre-synaptic vesicle
recycling was stimulated with elevated K+ (90 mM KCl for
1 min), and the cells were loaded with FM4–64, washed in
low-KCl buffer containing tetrodotoxin (TTX) to remove
excess FM4–64 and then ﬁxed. Over-expression of
IL1RAPL1 and IL1RAPL1△C increased the number of active
pre-synaptic compartments in contacting neurons (Fig. 2A and
B, mean+SEM FM4–64 relative intensity in neurons expres-
sing GFP: 113.0+3.9; HA-IL1RAPL1: 198.2.1+17.4;
HA-IL1RAPL1△C: 156.3+11.0; HA-IL1RAPL1△N:
98.3.1+4.2; ∗P , 0.01).
Finally, in IL1RAPL1 over-expressing neurons, but not in
neurons over-expressing IL1RAPL1△N, an increase in the
numberofpre-synapticcontactswasassociatedwithanincrease
of the miniature excitatory post-synaptic current (mEPSC) fre-
quency (Fig. 2C and D, mean+SEM mEPSC frequency of
neurons expressing GFP: 0.9+0.1 Hz; HA-IL1RAPL1:
1.5+0.2 Hz, P , 0.5; HA-IL1RAPL1△N: 0.85+0.25 Hz;
∗P , 0.05), whereas no modiﬁcation of the mEPSC amplitude
was observed (Fig. 2C and E; mEPSC amplitude of neurons
expressing GFP: 13.6+0.3 pA; HA-IL1RAPL1: 12.8+
0.3 pA; P ¼ 0.07; HA-IL1RAPL1△N: 13.3+0.5 Hz). These
data suggest that IL1RAPL1 may act as a synaptogenic
protein and that the extracellular domain is required to induce
pre-synaptic formation, although both the extracellular and
intracellular domains are required for inducing dendritic spine
formation.
The extracellular domain of IL1RAPL1 is necessary
to induce pre-synaptic clustering
Our data suggest that both IL1RAPL1 and IL1RAPL2 may
function as synaptic cell adhesion proteins. To corroborate
this hypothesis, we performed a neuron-ﬁbroblast co-culture
assay (15).
COS-7 cells transfected with GFP (negative control),
neuroligin-2 (positive control), HA-IL1RAPL1 (either full-
length or lacking the extracellular domain, IL1RAPL1△N)
or HA-IL1RAPL2 were co-cultured with hippocampal
neurons at DIV 8. After 3 days of co-culture, we ﬁxed the
4798 Human Molecular Genetics, 2011, Vol. 20, No. 24cells, and the pre-synapses were visualized using an antibody
against synapsin I.
COS-7 cells expressing wild-type (wt) IL1RAPL1,
IL1RAPL2 and neuroligin-2, but not IL1RAPL1△N,
induced pre-synaptic differentiation in contacting axons,
showing signiﬁcantly higher levels of synapsin I intensity
compared with the COS-7 cells expressing GFP (Fig. 2F
and H, mean+SEM synapsin intensity staining measured
over COS-7 cells transfected with GFP: 55.9+4.0;
IL1RAPL1: 321.2+32.3; IL1RAPL2: 253.9+19.6;
IL1RAPL1△N: 62.5+10.0; neuroligin-2: 731.5+154.3;
∗P , 0.05). However, IL1RAPL1-expressing COS-7 cells
were not able to recruit VGAT-positive pre-synaptic term-
inals (Fig. 2G).
Figure 1. IL1RAPL1 and IL1RAPL2 promote dendritic spine and excitatory synapse formation. (A) A schematic representation of IL1RAPL1/2, IL1RAPL1△C
and IL1RAPL1△N. (B) Hippocampal neurons were transfected at DIV 9 with GFP alone or with GFP and HA-IL1RAPL1, HA-IL1RAPL1△C,
HA-IL1RAPL1△N or HA-IL1RAPL2 constructs as indicated and stained at DIV 16 for GFP and HA (only the GFP channel is shown) (scale bars ¼
10 mm). (C and D) Quantiﬁcation of spine density (number of spines per 10 mm of dendrite length), head width (mm) and length (mm) in neurons transfected
as described in (A) (16 neurons examined for each construct). We then calculated mean and SEM between the values we obtained for the each neurons trans-
fected with the same cDNA. Histograms represent the mean+SEM (∗P , 0.01). (E and F) Hippocampal neurons were transfected at DIV 9 with GFP,
HA-IL1RAPL1, HA-IL1RAPL1△C, HA-IL1RAPL1△N or HA-IL1RAPL2 and stained at DIV 16 with GFP or HA and VGLUT1 (E) or VGAT (F) antibodies.
Each row of images shows double-labeling for GFP or HA (green, left panel) and VGLUT1 or VGAT (red, middle panel); the merged images are shown in color
in right panel (scale bar ¼ 10 mm). (G and H) Quantiﬁcation of VGLUT1 (G) and VGAT (H) cluster intensity in neurons over-expressing the IL1RAPL1 and
two constructs (at least nine neurons were analyzed for each construct). Bar graphs show the mean+SEM of the dendritic VGLUT1 and VGAT intensity nor-
malized to the GFP-transfected neurons (∗P , 0.01).
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may act as synaptogenic molecules for excitatory synapses
that interact with an unknown pre-synaptic partner.
IL1RAPL family proteins speciﬁcally interact with PTPd
Toidentify the receptorforIL1RAPL1,weused theIL1RAPL1
extracellular domain coupled to Fc (Fc-IL1RAPL1-N) or
control Fc proteins and protein A beads for column puriﬁcation
of synaptosomal membrane proteins from P18 rat brains that
bound Fc-IL1RAPL1 (Supplementary Material, Fig. S1).
IL1RAPL1-associated proteins were then analyzed by MudPit
tandemmassspectrometry(16).Wefoundlessthan200proteins
that co-precipitated with Fc-IL1RAPL1-N (Supplementary
Material, Fig. S1). Among these, some proteins were common
with Fc alone, and other proteins were cytosolic molecules or
enzymes.Amongthefewtransmembranepre-synapticproteins,
PTPdwasprecipitated.PTPd,togetherwithLARandPTPs,isa
Figure 2. IL1RAPL1 and IL1RAPL2 promote functional excitatory synapse formation. (A) FM1–64 staining (at DIV 16) of functional pre-synaptic terminals on
hippocampal neurons transfected at DIV 9 with GFP alone or with GFP and HA-IL1RAPL1, HA-IL1RAPL1△C or HA-IL1RAPL1△N (scale bar ¼ 10 mm). (B)
Quantiﬁcation of puncta density of FM1–64 staining of transfected cells (at least nine neurons analyzed for each construct). Histograms represent the mean+
SEM FM1–64 staining intensity normalized to GFP-transfected neurons (∗P , 0.01). (C) Typical recording of mEPSCs of neurons transfected with GFP alone
or GFP plus HA-IL1RAPL1 or HA-IL1RAPL1△N. (D and E) Bar graphs representing the mean mEPSC frequency+SEM (D) and mean mEPSC amplitude+
SEM (E) (at least 16 neurons were recorded for each construct; ∗P , 0.01). (F and G) IL1RAPL1 and IL1RAPL2 are able to induce synapsin I clustering in
contacting axons of co-cultured neurons. HEK293T cells expressing GFP alone or GFP plus IL1RAPL1, IL1RAPL2, IL1RAPL1△N or Ngl2 were co-cultured
with hippocampal neurons and stained for synapsin I (F), or VGAT (G) (scale bar ¼ 20 mm). (H) Quantiﬁcation of the mean+SEM intensity of synapsin I
clusters induced by IL1RAPL1, IL1RAPL2, IL1RAPL1△N or Ngl2. Integrated ﬂuorescence intensity of synapsin I was normalized to the cell area (at least
20 cells were analyzed; ∗P , 0.01).
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membrane proteins that bind to netrin-G ligand-3 (NGL-3) and
induce pre- and post-synaptic differentiation in neurons.
To conﬁrm the interaction, we initially examined whether
membrane-associated PTPd could regulate the accumulation of
IL1RAPL1 at contact sites. HEK293FT cells were transfected
with PTPd-ecto-pDisplay or HA-IL1RAPL1. One day after trans-
fection, the cells were co-cultured, and the subcellular distribution
of the two proteins was observed. Interestingly, HA-IL1RAPL1,
but not HA-IL1RAPL1△N, showed enhanced accumulation at
sites of contact with PTPd-transfected cells (Fig. 3A).
To determine whether IL1RAPL1 speciﬁcally bound PTPd
and not other PTP family members, we performed a similar
set of experiments with LAR and PTPs; neither protein
showed enhanced accumulation at sites of contact with
IL1RAPL1-transfected cells (Fig. 3A). Similarly, IL1RAPL2
speciﬁcally interacted with PTPd but not with the other
members of the PTP family (Supplementary Material, Fig. S2).
We also tested the interaction between IL1RAPL1 and other
transmembrane synaptic partners, including neurexins. Again,
we did not ﬁnd other interactors among the analyzed proteins
(Supplementary Material, Fig. S3).
The speciﬁc interaction between IL1RAPL1 and PTPd was
also conﬁrmed by immunoprecipitation. For this experiment,
HEK293FT cells were transfected with full-length IL1RAPL1
or IL1RAPL1△N. Another set of cells was transfected with
PTPd, LAR or PTPs. The lysates obtained from the transfected
cells were mixed 1:1 and immunoprecipitated using antibodies
speciﬁc for the intracellular domain of IL1RAPL1 (14). As
shown in Figure 3B, IL1RAPL1 but not IL1RAPL1△N immu-
noprecipitated only PTPd.
Theseresultssuggestthatpost-synapticIL1RAPL1enhances
the maturation of pre-synaptic terminals by its trans-synaptic
interaction with membrane-bound PTPd.
The intracellular domain of IL1RAPL1 interacts
with RhoGAP2
As shown in Figure 1, the IL1RAPL1 intracellular domain is
required to induce dendritic spine formation, and this activity
is not dependent on the interaction with PSD-95 (14). There-
fore, we sought to identify proteins that bind to IL1RAPL1
in the intracellular domain that might be required for dendritic
spine formation. We used the yeast two-hybrid system with
the intracellular C-terminal tail of IL1RAPL1 (amino acids
390–696; Fig. 4A) as bait to screen a human fetal brain
cDNA library. Four prey cDNA clones were isolated (clones
14, 25, 27 and 37; Fig. 4A), all of which encoded
RhoGAP2, a novel RhoGTPase-activating protein II.
The sites of interaction between IL1RAPL1 and RhoGAP2
were further studied using a yeast two-hybrid system using the
full-length IL1RAPL1 C-terminus containing the TIR domain
(amino acids 390–696), the TIR domain plus 18 amino acids
of the distal region of the C-terminus (amino acids 390–580),
the TIR domain alone (amino acids 403–562) or the
IL1RAPL1 C-terminus lacking the TIR domain (amino acids
560–696) as bait.
For prey, the following constructs were tested (Fig. 4B): the
RhoGAP full-length C-terminus (amino acids 441–698) and
three C-terminal fragments (amino acids 430–580, 500–698
and 560–698) (Fig. 4B).
Only two RhoGAP2 constructs [full-length RhoGAP2
C-terminus and a C-terminal fragment (amino acids 500–
698)] interacted with wt IL1RAPL1 (with an intact C-
terminal tail) and with the TIR domain (amino acids 390–
580, 403–562). None of the RhoGAP2 constructs interacted
with the IL1RAPL1 construct missing the TIR domain
(amino acids 560–696) (Fig. 4B). These data show that
IL1RAPL1 and RhoGAP2 interact and that the TIR domain
of IL1RAPL1 is necessary for interaction in the two-hybrid
system.
We further investigated the interaction between IL1RAPL1
and RhoGAP2 in transfected COS-7 cells and neuronal protein
extracts using pull-down and co-immunoprecipitation experi-
ments. First, we performed a GST pull-down assay using
COS7 cells. GST was fused to the IL1RAPL1 TIR domain
(amino acids 403–562) or the IL1RAPL1 C-terminal frag-
ments (amino acids 551–607, 608–684 or 560–696) and
Figure 3. The extracellular domain of IL1RAPL1 interacts with that of PTPd.
(A) Two sets of HEK293FT cells were transfected with IL1RAPL1 or
IL1RAPL1△N and with the Myc-tagged constructs of LAR-ecto-pDis
(LAR), PTPd-ecto-pDis (PTPd) and PTPs-ecto-pDis (PTPs) for 16 h using
the calcium phosphate precipitation method. Cells expressing the proper con-
struct were plated together on a 16 mm cover slip and grown for 24 h before
ﬁxation and staining with IL1RAPL1 or Myc (35). (B) Cells were transfected
as described in (A), and the lysate was mixed 1:1 and immunoprecipitated with
antibodies against IL1RAPLA1. The eluent was analyzed by western blot
using IL1RAPL1 and Myc antibodies.
Human Molecular Genetics, 2011, Vol. 20, No. 24 4801tested for binding to full-length myc-RhoGAP2. As expected,
the TIR domain of IL1RAPL1 precipitated full-length
myc-RhoGAP2. In addition, the 560–696 and 608–684 frag-
ments precipitated myc-RhoGAP2. We then generated an anti-
body that speciﬁcally recognizes RhoGAPII (see Experimental
Procedures, Supplementary Material, Fig. S4A for details) and
showed that the TIR domain and the last 132 amino acids of
the IL1RAPL1 C-terminus interact with RhoGAP2 present
in rat brain lysates (Fig. 4E).
These data indicate that the IL1RAPL1–RhoGAP2 inter-
action is complex and involves different regions of the
C-terminal end of IL1RAPL1 (Fig. 4C and E).
Next, we found that HA-IL1RAPL1 was speciﬁcally
co-immunoprecipitated with myc-RhoGAP2 in transfected
COS-7 cells, but HA-IL1RAPL1 with the C-terminus
deleted (HA-IL1RAPL1△C) was not (Fig. 4D). Finally,
immunoﬂuorescence labeling of hippocampal neurons showed
that endogenous IL1RAPL1 and RhoGAP2 co-localized to
Figure 4. The intracellular domain of IL1RAPL1 interacts with RhoGAP2. (A) Schematic representation of IL1RAPL1 and the C-terminal domain of
IL1RAPL1, which was used as bait for the yeast two-hybrid screening. Also shown are the results of the yeast two-hybrid screening with a schematic repre-
sentation of the four positive clones for RhoGAP2. The two-hybrid interaction was quantiﬁed based on the activation of the three reporter genes (HIS3,
LacZ and URA 3) (3+: activation of all three reporter genes; 2+: activation of HIS3 and LacZ reporters; 1+: activation of HIS3). The small numbers refer
to amino acid residues. (B) Mapping of the IL1RAPL1/RhoGAP2 interaction using the two-hybrid assay. We used the full-length C-terminus of IL1RAPL1
(amino acids 390–696), the TIR domain (amino acids 403–562) and two other fragments from the C-terminus of IL1RAPL1 (amino acids 390–580 and
560–696) as bait and four fragments of the C-terminus of RhoGAP2 (amino acids 441–698, 430–580, 500–698, 560–698) as prey. The full-length
IL1RAPL1 C-terminus and the TIR domain constructs interacted with the RhoGAP2 C-terminal tail (3+). (C–E) GST pull-down experiments using
IL1RAPL1 and RhoGAP2. Diagram of the four fragments of the C-terminal tail of IL1RAPL1 used in the GST pull-down assay (top). In COS7 cells transfected
with mycRhoGAP2, the TIR domain of IL1RAPL1 (amino acids 403–562), as well as the amino acids 608–684 and amino acids 560–696 fragments, pulled
down full-length RhoGAP2 (mycRhoGAP2). The puriﬁed GST-amino acids 403–562 and GST-amino acids 560–696 fragments bound to RhoGAP2 in lysates
from the rat brain. (D). Interaction between IL1RAPL1 and RhoGAP2 was conﬁrmed by co-immunoprecipitation experiments using COS7 cells. Myc-tagged wt
RhoGAP2 co-immunoprecipitated with HA-IL1RAPL1, whereas the mutated form of IL1RAPL1 (HA-IL1RAPL1 DC) did not. (F) Representative images of the
staining and co-localization of endogenous IL1RAPL1 and RhoGAP2 in hippocampal neurons (scale bar ¼ 10 mm).
4802 Human Molecular Genetics, 2011, Vol. 20, No. 24dendritic spines (Fig. 4F). These ﬁndings demonstrate the
association of IL1RAPL1 with RhoGAP2.
RhoGAP2 is localized to excitatory synapses
We then asked whether RhoGAP2 is localized to the post-
synaptic site of the excitatory synapses, as suggested by its
interaction with IL1RAPL1. We found that RhoGAP2 is
expressed in the cortex, the cerebellum and the hippocampus
(Supplementary Material, Fig. S4A) and in the cortex and
hippocampus in mice during development (Supplementary
Material, Fig. S4B). Using subcellular fractionation, we also
showed that RhoGAP2 is present in the synaptosomal fraction
(Supplementary Material, Fig. S2B). The synaptic subcellular
localization of RhoGAP2 was further studied by multiple-
immunolabeling experiments in cultured hippocampal
neurons, using anti-GluR1, anti-GluR2, anti-PSD-95, anti-
Shank, anti-Bassoon, anti-synaptophysin and anti-V-GAT
antibodies. Endogenous RhoGAP2 was mostly co-localized
with PSD-95 and Shank1 proteins (percent of IL1RAPL1
co-localized with GluR2/3: 77.3%+2.3; with GluR1:
74.4%+3.6; with PSD-95: 71.2%+1.9; with Shank1:
66.8%+4.2; with Bassoon: 52.3%+2.8; and with synapto-
physin 56: 3%+3.9) (Supplementary Material, Fig. S2C
and D), which are markers of excitatory post-synapses.
Moreover, only 5%+1.2 of the endogenous RhoGAP2
co-localized with V-GAT (Supplementary Material, Fig. S4C
and D). These results suggest that RhoGAP2 is enriched in
the post-synaptic compartment.
We also examined the effect of over-expressing RhoGAP2
in mature neurons on the staining of endogenous pre- and post-
synaptic markers. In neurons over-expressing mycRhoGAP2,
there was a signiﬁcant increase in the number of puncta con-
taining synaptophysin (relative to GFP-transfected neurons,
11.86+0.64 versus 8.5+0.44; P , 0.01), Bassoon (relative
to control, 8.9+0.39 versus 6.42+0.51; P , 0.05), Shank1
(relative to GFP transfected neurons, 9.9+0.45 versus
7.3+0.34; P , 0.01) and PSD-95 (relative to control;
10.3+0.63 versus 6.7+0.45; P , 0.01) but not GluR1 (rela-
tive to GFP transfected neurons, 8.16+0.33 versus 7.7+
0.41) or GluR2 (relative to GFP-transfected neurons, 8.4+
0.21 versus 7.1+0.33) (Fig. 5A and B).
We also found that spines of mycRhoGAP2-over-
expressing cells showed increased staining intensity for synap-
tophysin (relative to control, 3.1+0.55 versus 1.3+0.21;
P , 0.01), Bassoon (relative to control, 2.8+0.58 versus
1.5+0.6; P , 0.05), Shank1 (relative to control, 3.9+0.45
versus 2.4+0.7; P , 0.01) and PSD-95 (relative to control,
3.8+0.55 versus 2.4+0.63; P , 0.01), but not GluR1 (rela-
tive to control, 3.3+0.27 versus 2.8+0.31) or GluR2 (rela-
tive to control, 2.7+0.27 versus 2.2+0.45) (Fig. 5A and B).
These data demonstrate that RhoGAP2 is a novel synaptic
RhoGAP that interacts with IL1RAPL1 and might contribute
to excitatory synapse formation.
RhoGAP2 is recruited to synapses by the IL1RAPL1/PTPd
interaction
We then determined whether the interaction between
IL1RAPL1 and PTPd is required for RhoGAP2 recruitment
and function in excitatory synapses. We over-expressed wt
IL1RAPL1 and mutants and stained for endogenous
RhoGAP2 expression. We found that the over-expression
of IL1RAPL1 signiﬁcantly increased both endogenous
RhoGAP2 and synapsin staining compared with b-Gal-over-
expressing neurons (Fig. 6A–C). The over-expression of
both IL1RAPL1△C (unable to bind to RhoGAP2) and
IL1RAPL1△N (unable to bind to PTPd) did not increase the
staining of endogenous RhoGAP2 (Fig. 6A and B), whereas
only IL1RAPL1△C increased the synapsin staining (Fig. 6A
and C) (Fig. 6B, mean+SEM normalized intensity staining
of endogenous RhoGAP2 in neurons over-expressing b-Gal:
51.9+2.7; IL1RAPL1: 76.0+4.3; IL1RAPL1△C: 57.0+
2.9; IL1RAPL1△N: 44.6+1.9; ∗P , 0.05. Fig. 6C, mean+
SEM normalized staining intensity of endogenous synapsin
in neurons over-expressing b-Gal: 93.6+6.3; IL1RAPL1:
376.5+31.7; IL1RAPL1△C: 301.5.0+25.0; IL1RAPL1△N:
91.5+10.5; ∗P , 0.05). These data suggest that IL1RAPL1
binds and recruits RhoGAP2 to synapses via its intracellular
domain, and binding of PTPd at the extracellular domain is
also required. To conﬁrm these ﬁndings, neurons over-
expressing IL1RAPL1 were incubated with puriﬁed Fc or
Fc-IL1RAPL2 for 6 days, which should compete with the
binding between IL1RAPL1 and PTPd. We found that
Fc-IL1RAPL2 was able to signiﬁcantly reduce both
RhoGAP2- and synapsin-induced recruitment by IL1RAPL1
(Fig. 6A–C) (Fig. 6B, mean+SEM normalized intensity
staining of endogenous RhoGAP2 in neurons over-expressing
IL1RAPL1 and incubated with Fc: 76.6.9+3.9; incubated
with Fc-IL1RAPL2: 58.5.0+5.5; §P , 0.05. Fig. 6C,
mean+SEM normalized intensity staining of endogenous
synapsin in neurons over-expressing IL1RAPL1 and incubated
with Fc: 337.2+6.3; incubated with Fc-IL1RAPL2: 189.2+
25.5; §P , 0.05). We also measured the level of
co-localization of endogenous RhoGAP2 with synapsin and
found that the over-expression of IL1RAPL1△C does not
reduce signiﬁcantly the level of RhoGAP2 that co-localizes
with synapsin (data not shown), suggesting that IL1RAPL1
might not be necessary for RhoGAP2 localization at synapses.
Thus, our data suggest that the interaction between
IL1RAPL1 and PTPd induces pre-synaptic maturation, and
the interaction with RhoGAP2 increases post-synaptic cluster
and dendritic spine formation. To further support this
ﬁnding, we over-expressed wt RhoGAP2 or RhoGAP2△C
(unable to bind IL1RAPL1; we inserted a stop codon at
amino acid 500) and GFP in hippocampal neurons and deter-
mined the dendritic spine number and morphology. We found
that the over-expression of RhoGAP2 increased the dendritic
spine number without changing the shape, whereas the over-
expression of RhoGAP2△C signiﬁcantly altered the shape of
dendritic spines, which became longer and thinner compared
with neurons over-expressing GFP (Fig.7A) (Fig. 7B,
mean+SEM dendritic width, mm, in neurons expressing
GFP: 0.8+0.01; RhoGAP2: 0.9+0.02; RhoGAP2△C:
0.5+0.03; ∗P , 0.05. Fig. 7B, mean+SEM dendritic
length, mm, in neurons expressing GFP: 1.4+0.3;
RhoGAP2: 1.5+0.2; RhoGAP2△C: 2.5+0.3; ∗P , 0.05.
Fig. 7C, mean+SEM dendritic spines number in neurons
expressing GFP: 4.3+0.2; RhoGAP2: 6.2+0.3;
RhoGAP2△C: 3.4+0.3; ∗P , 0.05).
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In this study, we showed that the MR-related protein
IL1RAPL1 is a synaptic adhesion protein that binds trans-
synaptically to PTPd through its extracellular domain and to
RhoGAP2 through its intracellular domain.
Cell adhesion proteins are thought to be key regulators of
synaptogenesis. In particular, these proteins are involved in
both the initial phase of synaptogenesis, during cell-type-
speciﬁc target recognition, and the synapse maturation
phase, during which the protein components of the pre-
synaptic release machinery and the post-synaptic signaling
apparatus are recruited to the nascent synaptic contact (17).
These proteins are known to induce synaptic specialization
in neurons when over-expressed in ﬁbroblasts during
co-culture experiments.
We previously showed that IL1RAPL1 is a transmembrane
protein located at post-synaptic densities of excitatory synap-
ses (14) that can induce pre-synaptic differentiation when
over-expressed in neuronal cultures. Here, we found that
the IL1RAPL1 extracellular domain interacts with PTPd,a
pre-synaptic protein involved in synapse formation.
This interaction was found using non-biased
Fc-IL1RAPL1 afﬁnity chromatography and mass-
spectrometry analysis using brain extract and then conﬁrmed
by HEK cell trans-clustering assays and immunoprecipita-
tion by trans-interaction.
PTPd is a member of the LAR phosphor-tyrosine phos-
phatase family, which also includes LAR and PTPs (18).
All three members of the family are speciﬁcally involved
in synapse formation by binding to NGL-3 through the
FNIII domain (15,19). It has also been found that the Ig
Figure 5. RhoGAP2 increases the number of synapses and the accumulation of endogenous synaptic proteins. (A) Hippocampal neurons at DIV 14 were trans-
fected with mycRhoGAP2 or with the GFP control and were stained at DIV 22. Each row of images shows a double-labeling of mycRhoGAP2 or GFP (green,
left panel) and Bassoon, synaptophysin, PSD-95, Shank1, GluR1 or GluR2 (red, middle panel); the merged images are shown in color in the right panel. Indi-
vidual channels are shown in gray scale (scale bars ¼ 10 mm). (B) Quantiﬁcation of puncta density and synaptic staining intensity of Bassoon, synaptophysin,
PSD-95, Shank1, GluR1 and GluR2 after over-expression of mycRhoGAP2 (.7 neurons analyzed for each protein; 40–70 synapses scored per neuron). Quan-
tiﬁcation of the mean percent of co-localization (6 SEM) of endogenous RhoGAP2 clusters with endogenous GluR2/3, GluR1, PSD-95, Shank1, Bassoon, synap-
tophysin and V-GAT.
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suggesting that multiple proteins can contribute to the pre-
synaptic differentiation of the LAR-PTP families (20). In
this study, we found that PTPd can speciﬁcally trans-
synaptically bind to a second and a third partner,
IL1RAPL1 and its paralog IL1RAPL2.
It was previously demonstrated that PTPd is the only LAR
family member that is not able to induce post-synaptic differ-
entiation, such as PSD-95 accumulation, when added to neur-
onal cultures (19). However, our data showed that the ability
of IL1RAPL1 to induce dendritic spine formation requires
both the extracellular and the intracellular domains.
Using yeast two-hybrid screening, we identiﬁed RhoGAP2
as a new intracellular partner of IL1RAPL1, and our data
suggest that the IL1RAPL1 and RhoGAP2 interaction is
required for the ability of IL1RAPL1 to induce dendritic
spine formation.
Indeed, we previously showed that IL1RAPL1 binds to
PSD-95; however, this interaction is not required for the
IL1RAPL1-mediated increase in the number of dendritic
spines (14). In this study, we showed that the intracellular
domain also binds to RhoGAP2, a GTPase-activating protein
previously shown to inhibit Rac1 activity (21). However,
because the deletion of most of the N- or C-terminal region
of IL1RAPL1 used in our experiments not only disrupts
binding of IL1RAPL1 to PTPd and RhoGAP2, but also
binding to any other possible known and unknown interacting
proteins, we cannot totally exclude that other IL1RAPL1
Figure 6. The IL1RAPL1/PTPd complex recruits RhoGAP2 to synapses. (A) Hippocampal neurons were transfected with b-Gal, HA-IL1RAPL1,
HA-IL1RAPL1△C or HA-IL1RAPL1△N at DIV 9, ﬁxed at DIV 16 and triple-stained for b-Gal, IL1RAPL1, RhoGAP2 and synapsin. Two sets of neurons
transfected with IL1RAPL1 were treated with Fc or FcIL1RAPL2, as indicated in the panels. Each row of images shows triple-labeling for HA (red, left
panel), RhoGAP2 (green, middle left panel) and synapsin (blue, middle right panel); merged images are shown in color in the right panel (scale bar ¼
10 mm). (B and C) Quantiﬁcation of RhoGAP2 (B) and synapsin (D) cluster intensity in neurons over-expressing IL1RAPL1 constructs (at least nine
neurons were analyzed for each construct). Bar graphs show the mean+SEM of dendritic RhoGAP2 and synapsin intensity normalized to GFP-transfected
neurons (∗P , 0.01). Two sets of HEK293FT cells were transfected with IL1RAPL1 with or without RhoGAP2 and with the Myc-tagged construct
PTPd-ecto-pDis (PTPd) for 16 h using the calcium phosphate precipitation method. Cells expressing the proper constructs were plated together on a 16 mm
cover slip and grown for 24 h before ﬁxation and staining for IL1RAPL1, Myc and RhoGAP2.
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formation.
Our biochemical and morphological data suggest that
RhoGAP2 is localized to excitatory synapses, and its
C-terminal tail interacts with the TIR domain of IL1RAPL1,
although pull-down experiments suggest a possible additional
interaction at the C-terminal tail.
RhoGAP proteins increase the intrinsic GTPase activity to
inactivate the RhoGTPase switch and guanine-nucleotide dis-
sociation inhibitors (22). Rho proteins have been implicated in
different aspects of neuronal morphogenesis, including
dendritic arbor development and spine morphogenesis (23).
In particular, Rac1 positively regulates and RhoA negatively
regulates dendritic spine morphogenesis (24).
Surprisingly,wefoundthattheover-expression ofRhoGAP2
induces both excitatory synapse and dendritic spine formation.
However, the over-expression of a RhoGAP2 mutant that does
not bind to IL1RAPL1 causes a drastic change in spine shapes
which are converted to ﬁlopodia-like shape. Thus, our data
suggest that the RhoGAP2 activity on dendritic spines is
regulated by the interaction with IL1RAPL1/PTPd complex.
Although the function of the IL1RAPL1–RhoGAP2 inter-
action remains to be deﬁned, we found that RhoGAP2 is
recruited to synapses by the PTPd–IL1RAPL1 interaction,
as suggested by the ﬁnding that endogenous RhoGAP2 stain-
ing is increased at synapses when IL1RAPL1 is over-
expressed or when the interaction between IL1RAPL1 and
PTPd is inhibited by Fc-IL1RAPL2.
In conclusion, we show for the ﬁrst time that IL1RAPL1
and its paralog ILRAPL2 are synaptic adhesion molecules
that contribute to synapse formation, and alteration of this
pathway might contribute to the development of ID in patients
with IL1RAPL1 mutations.
MATERIALS AND METHODS
Antibodies
The following antibodies were used: rabbit anti-IL1RAPL1
(K10) (14), rabbit anti-RhoGAP2 (QQ15) raised against the
peptide CysGHRRASSGDRLKDTGSVQRLSTYD (amino
acids 659–677), rabbit anti-VGlut1 (Synaptic System), mouse
anti-VGAT (NeuroMab), mouse anti-synapsin (Sigma), mouse
anti-Bassoon (Synaptic System), guinea pig anti-Shank1 (gift
from E. Kim, KAIST), mouse anti-PSD-95 K28/43 (Neuro-
Mab), mouse anti-GluR2 (Chemicon, International S.C.),
rabbit anti-GluR1C-term (Chemicon International), mouse
anti-synaptophysin (Sigma), rabbit anti-HA-tag (Santa Cruz
Biotechnology), mouse anti-HA-tag (Roche Applied Science),
rabbit anti-Myc-tag (Sigma) and mouse anti-b-galactosidase
(Promega, Madison, WI, USA).
cDNA constructs
Full-length or deletion HA-IL1RAPL1 constructs have been
previously described (14). IL1RAPL2 cDNA was ﬁrst
obtained by Kristi Palmer (Amgen) and then sub-cloned into
the GW1–2b-GluR2 Signal peptide-HA vector. For the
IL1RAPL1△C construct, we inserted a stop codon at amino
acid 459, and for the IL1RAPL1△N construct, we deleted
the ﬁrst 242 amino acids.
For the chromatography assay, the IL1RAPL1 extracellular
domain (amino acids 1–353) was cloned into the NheI/KpnI
sites of the pEGFP-N1 vector in which EGFP was replaced
with a human Fc domain (19). Myc- and HA-tagged
LAR-ecto-pDis, PTPd-ecto-pDis and PTPs-ecto-pDis have
been previously described (19). Neuroligin2-HA has been
previously described (25).Neurexin1b-CFP, Neurexin1a-CFP,
Figure 7. Dendritic spine number and morphology of hippocampal neurons are regulated by RhoGAP2. (A) Hippocampal neurons at DIV 9 were transfected
with GFP alone or with GFP and Myc-RhoGAP2 or GFP and Myc-RhoGAP2△C, as indicated on the panels. After 1 week, neurons were ﬁxed and stained for
GFP and Myc. (B–D) Quantiﬁcation of the mean (+SEM) length (B), width (C) and number (per 10 mm) of dendritic spines. Over 14 transfected neurons from
four independent experiments were measured for each transfection (∗P , 0.01, Student’s t-test) (scale bar ¼ 10 mm).
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Netrin-G2, Myc-DASM-1, SALM1-GFP, SALM2-GFP,
SALM3-GFP, SALM4-GFP, NGL-3-GFP and NCAM140-
GFP constructs have been previously described (26,27).
RhoGAP2 cDNA was bought from Invitrogen and then
sub-cloned into the GW12b-myc plasmid. To develop
RhoGAP2△C, we inserted a stop codon at amino acid 500.
Cell culture, transfection, staining and quantiﬁcation
of primary rat hippocampal neurons
Low-density hippocampal neuronal cultures were prepared
from E18–E19 rat hippocampi as previously described
with minor modiﬁcations (28,29) and were grown in 12-well
Petri dishes (Iwaky Sterilin, Caerphilly, UK). Neurons were
transfected using the calcium phosphate precipitation method
on DIV 9, and experiments were performed 7 days after
transfection.
African green monkey kidney (COS-7) or HEK293T cells at
50–70% conﬂuency (24 h after plating in six-well plates;
Iwaky Sterilin, Caerphilly, UK) were transfected using Lipo-
fectaminew 2000 Transfection Reagent (Invitrogen, San
Diego, CA, USA) with cDNA expression constructs (1–2 mg
DNA/well) for 2–3 h in 5% CO2 at 378C. Cells were
washed twice with PBS, fed with DMEM containing 10%
FBS and 1% penicillin/streptomycin and grown for 24–48 h
before lysis for co-immunoprecipitation or pull-down assays.
Hippocampal neurons were ﬁxed in 4% paraformaldehyde
(PFA)–4% sucrose or 100% methanol at 2208 for 10 min.
Primary (1:50–1:400) and secondary (1:200) antibodies
were applied in GDB buffer [30 mM phosphate buffer
(pH 7.4) containing 0.2% gelatin, 0.5% Triton X-100 and
0.8 M NaCl].
Confocal images were obtained using a Zeiss 510 confocal
microscope (Carl Zeiss; a gift from F. Monzino) with a 63×
objective (numerical aperture 1.4) with sequential acquisition
settings of 1024 × 1024 pixels. Each image is a z-series
projection of about 7–15 images that were each averaged
two to four times and taken at 0.4–0.7 mm depth intervals.
Morphometric analysis and quantiﬁcation of dendritic spines,
synaptic protein staining and FM4–64 staining were per-
formed using the MetaMorph software (Molecular Devices,
Downingtown, PA, USA) by investigators who were blind to
the type of transfection and experimental manipulation.
Labeled, transfected neurons were chosen randomly for
quantiﬁcation from six cover slips from six independent
experiments for each construct.
The dendritic spine number and dimensions and the synapse
number were measured as described previously (29,30) with
minor modiﬁcations. For each neuron, we measured the
number of spines/synapses present in all the dendrites along
their entire length, thus we calculated the number of spines/
synapses present in the entire neuron. Then, we calculated
mean and SEM for the neurons transfected with the same
cDNA.
Fluorescence images and morphometric measurements were
made as described (14). FM1–43 staining was performed by
incubating neurons for 1 min in 6 mM FM1–43 (Molecular
Probes) in a high-potassium buffer followed by two washes
in Tyrode solution in the presence of 1 mM TTX (Tocris) as
previously described (31).
Electrophysiological recording of cultured hippocampal
neurons
Whole-cell patch-clamp recordings were taken from GFP-,
IL1RAPL1- or IL1RAPL1△N-transfected rat hippocampal
neurons as described above. Patch electrodes, fabricated
from thick borosilicate glass, were pulled and ﬁre-polished
to a ﬁnal resistance of 3–4 MV and ﬁlled with the standard in-
ternal solution [(in mM) 100 CsMES, 20 CsCl, 2 MgCl2,5
ethylene glycol tetraacetic acid, 10 HEPES, 4 ATP and 15
phosphocreatine (pH 7.4)]. EPSCs were investigated in cul-
tured neurons by superfusing the whole-cell clamped neuron
with a Tyrode solution containing (in mM): 150 NaCl, 2
CaCl2, 1 MgCl2, 4 KCl, 10 glucose and 10 HEPES (pH 7.4).
Neurons were voltage-clamped at –70 mV, and TTX
(0.3 mM) was added to block spontaneous action potential
propagation during the recording of mEPSCs. Each
experiment was performed at room temperature (22–248C).
Statistical analysis was performed using a two-tailed t-test.
Mixed-culture assay
Mixed co-culture assays were performed as described previ-
ously (32,33). Brieﬂy, cultured hippocampal neurons at DIV
8 were co-cultured with COS-7 cells expressing GFP,
HA-IL1RAPL1 (full-length or deletion mutants),
HA-IL1RAPL2 or HA-neuroligin2 in the presence of 0.5 mM
cytosine arabinoside to inhibit COS-7 cell proliferation.
Three days later, cells were ﬁxed and immunostained. Quanti-
ﬁcation of synapsin staining in the transfected COS-7 cells
was performed using the MetaMorph software (Molecular
Devices).
Afﬁnity chromatography
Afﬁnity chromatography for mass spectrometric identiﬁcation
of IL1RAPL1-binding proteins was performed as described
previously (34). Brieﬂy, HEK293FT cells were transfected
with the IL1RAPL1-ecto-Fc expression constructs and
grown in Opti-MEM (Invitrogen) for 10 days. Every 3 days,
the IL1RAPL1-ecto-Fc protein was puriﬁed from conditioned
293FT media using Protein A sepharose.
Fifteen P18 rat brains were homogenized in homogenization
buffer (0.32 M sucrose, 4 mM HEPES, pH 7.5, and protease
inhibitors) using a Dounce homogenizer. Homogenates were
centrifuged at 1000g for 15 min at 48C. Supernatants were
centrifuged again at 1000g for 15 min and then the resulting
supernatants were centrifuged for at 10 000g for 20 min. The
P2 pellet containing crude synaptosomes was resuspended in
homogenization buffer and centrifuged at 10 000g for
20 min, yielding the P2′ pellet containing washed crude synap-
tosomes. The P2′ pellet was extracted in 20 mM Tris (pH 8.0),
0.1 mM CaCl2 and 1% Triton X-100 for 30 min at 48Ct o
enrich for pre-synaptic proteins (35). The extracts were centri-
fuged at 10 000g for 30 min, and the supernatants were diluted
1:1 with extraction buffer. Protein A beads bound to 50 mg
human Fc control protein or 50 mg IL1RAPL1 ecto-Fc
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teins were eluted from the beads by incubation with 0.2 M
glycine (pH 2.2) and TCA-precipitated overnight.
The precipitate was boiled for 5 min and separated on Invi-
trogen Nupage gels. The nanoﬂow LC2MS/MS analysis was
performed using a Q-STAR mass spectrometer (PE-Sciex,
Canada) equipped with a nanoelectrospray ion source
(Proxeon Biosystems, Odense, Denmark).
HEK293FT cell adhesion proteins
HEK293FT cells at 70–80% conﬂuency (24 h after plating in
12-well plates) were transfected using the calcium phosphate
precipitation method with the cDNA expression constructs
(1–2 mg DNA per well) for 16 h, grown for an additional
3 h, collected and resuspended in DMEM (Lonza). To
examine protein interaction, cells expressing the proper con-
struct were plated together on a 16 mm cover slip and
grown for 24 h before ﬁxation with 4% PA supplemented
with 4% sucrose (36).
Yeast two-hybrid screening and cDNA constructs
For the two-hybrid experiments, a fragment corresponding to
the C-terminus of IL1RAPL1 (amino acids 390–696) was
cloned into the pDBLeu vector in frame with the GAL4-
binding domain and used as bait to screen a human fetal
brain cDNA library (ProQuest Pre-made cDNA Libraries),
which had been cloned into the pPC86 vector. Positive col-
onies grew on plates containing 10 mM 3-AT without trypto-
phan, leucine or histamine and expressed all three reporter
genes: HIS3, LacZ and URA3. cDNA plasmids from positive
clones were recovered using Escherichia coli DH5a plated on
Amp and sequenced.
For further two-hybrid experiments, four DNA fragments
corresponding to the IL1RAPL1 C-terminus—amino acids
390–580, 390–580, 403–562 and 560–696—were sub-
cloned into pDBLeu and used as bait; the DNA fragments cor-
responding to amino acids 441–698, 430–580, 500–698 and
560–698 of RhoGAP2 were sub-cloned into the pPC86
plasmid and used as prey. RhoGAP2 with the myc tag was
sub-cloned into the GW1-CMV expression vector (British
Biotechnology, UK). Truncated HA-ILRAPL1 and HA-
IL1RAPL1△C were developed using PCR ampliﬁcation and
the appropriate oligonucleotides; these were also sub-cloned
into the GW1-CMV expression vector with a HA-tag at the N-
terminus as previously described (14).
The GST-Il-RAPL1 fragments corresponding to amino
acids 403–562, 551–607, 608–684 and 560–696 were
cloned into the pGEX4T-3 vector.
Co-immunoprecipitation and GST pull-down assays
Transfected COS7 cells were lysed with buffer containing
50 mM Tris–HCl, 150 mM NaCl, 1 mM EDTA, 1% NP40,
0.5% deoxycholate, 0.05% SDS and protease inhibitors
(lysis buffer). Lysate samples (100 mg protein) were incubated
overnight at 48C with mouse anti-myc-tag antibodies (Santa
Cruz Biotechnology, CA, USA) at 5 mg/ml in buffer A
(200 mM NaCl, 10 mM EDTA, 10 mM Na2HPO4, 0.5%
NP-40, 0.1% SDS, 10 mM NaF and Ser/Thr- and Tyr-
phosphatase inhibitor cocktails).
Protein A agarose beads (Santa Cruz Biotechnology)
washed in buffer A were added, and the incubation continued
for 2 h. The beads were pelleted by centrifugation, washed ﬁve
times with buffer A, resuspended in sample buffer for SDS–
PAGE and boiled for 5 min. The beads were again pelleted
by centrifugation, and the supernatants were applied to 7.5%
SDS–PAGE. Protein bands were transferred to nitrocellulose
membranes (Amersham) at 80 V for 120 min at 48C.
Primary antibodies were applied overnight in blocking buffer
[20 mM Tris (pH 7.4), 150 mM NaCl, 0.1% Tween20 and 3%
dried non-fat milk]. Secondary antibodies (HRP-conjugated
anti-mouse or anti-rabbit) (Amersham) were used at a
1:2000 dilution. The signal was detected using an ECL detec-
tion system.
GST fusion proteins were prepared in E. coli BL21 and
puriﬁed by standard procedures. African green monkey
kidney COS-7 cells or rat brain homogenates were lysed in
lysis buffer [50 mM Tris–HCl (pH 7.4), 150 mM NaCl, 1 mM
EDTA, 1% NP40 and 0.5% deoxycholate]. Lysates were
then incubated with 30 mg of GST fusion protein immobilized
on GST 4B beads (GE Healthcare) for 3 h at 48C, washed ex-
tensively ﬁve times in the lysis buffer and resuspended in
25 ml of 3× SDS sample buffer. GST alone was used as a
control. Samples were separated by SDS–PAGE followed
by western blot analysis. For GST pull-down experiments,
hippocampal neuron lysates and rat brain extracts were incu-
bated with 30 mg GST fusion protein immobilized on GST
4B beads (GE Healthcare) for 3 h at 48C, washed ﬁve times
in lysis buffer, and resuspended in 25 ml SDS sample buffer.
GST alone served as a control. Samples were separated by
SDS–PAGE followed by western blot analysis using the
appropriated antibodies.
The following antibodies and dilutions were used: rabbit
anti-Myc-tag (1:200; Upstate Cell Signaling Solutions) and
rabbit anti-RhoGAP2 (1:500; in-house).
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
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